Dr. Ariane M. Davison
Dr. Ariane M. Davison is a virologist, immunologist and epidemiologist, with almost 20 years of experience in biotechnology, start-ups, equities and international consulting.
She has held senior operational and business development roles at venture-backed biotech companies in Hong Kong, Singapore, mainland China and the United States.
In 2011 she secured a “First In Class” U.S. FDA 510(k) class II medical device approval for a new ASTM antiviral face mask. In 2013, Ariane was selected for the Kauffman Fellows Venture Capital Fellowship in Silicon Valley. She currently works in corporate strategy for a biotech company in Singapore and the U.S.
Ariane earned her Doctorate in Medicine, specializing in Immunology and Vaccines from the University of Sydney Medical School on scholarship. Her Honors is in Molecular Genetics and Epidemiology. Her original scientific work has been published in medical journals and textbooks. She also has been a speaker at numerous international medical and investment conferences.